Personalised recommendations for hospitalised patients with Acute Kidney Injury using a Kidney Action Team (KAT-AKI): protocol and early data of a randomised controlled trial
Aklilu A, O’Connor K, Martin M, Yamamoto Y, Coronel-Moreno C, Shvets K, Jones C, Kadhim B, Corona-Villalobos C, Baker M, Tan J, Freeman N, Groener M, Menez S, Brown D, Culli S, Lindsley J, Orias M, Parikh C, Smith A, Sundararajan A, Wilson F. Personalised recommendations for hospitalised patients with Acute Kidney Injury using a Kidney Action Team (KAT-AKI): protocol and early data of a randomised controlled trial. BMJ Open 2023, 13: e071968. PMID: 37068906, PMCID: PMC10111926, DOI: 10.1136/bmjopen-2023-071968.Peer-Reviewed Original ResearchConceptsPrimary teamAcute Kidney Injury OutcomesAKI alert systemInvestigator-blinded trialUsual care armKey secondary outcomesClinical decision support toolIntensive care unitUS hospital systemAKI alertsAKI detectionAKI progressionCare armSecondary outcomesPrimary outcomeCare unitMedian timeMedical floorPercentage of recommendationsDiagnostic interventionsInjury outcomesRandomisationHospital systemEthics CommitteeDedicated teamRenal Considerations in Critically Ill Hematopoietic Stem Cell Transplant Patients
Aklilu A, Renaghan A. Renal Considerations in Critically Ill Hematopoietic Stem Cell Transplant Patients. 2023, 351-364. DOI: 10.1007/978-3-031-28797-8_27.Peer-Reviewed Original ResearchHematopoietic stem cell transplantationAcute kidney injuryKidney injuryRisk factorsIncidence of AKIPrognosis of AKIHematopoietic stem cell transplant patientsPost-transplant risk factorsTransplant-associated thrombotic microangiopathyStem cell transplant patientsHepatic sinusoidal obstruction syndromePost-transplant complicationsChronic kidney diseaseIndependent risk factorSinusoidal obstruction syndromeCell transplant patientsKidney replacement therapyStem cell transplantationIntensive care unitHospital mortalityNephrotoxic medicationsRenal considerationsVentilator requirementEngraftment syndromeHSCT recipients